drugset / Trial / NCT04210973

Comparison of Anyu Peibo With Placebo in Treatment of MDD in China

NCT04210973 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Anyu Peibo Capsule comparing with placebo in the treatment of Chinese Patients with Depression.

Timeline

Start
2020-01-23
Primary completion
2020-12
Completion
2021-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Anyu Peibo Unknown 0.8 g Oral